These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15269190)

  • 1. Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.
    Sanderson L; Taylor GW; Aboagye EO; Alao JP; Latigo JR; Coombes RC; Vigushin DM
    Drug Metab Dispos; 2004 Oct; 32(10):1132-8. PubMed ID: 15269190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major phase I biotransformation pathways of Trichostatin a in rat hepatocytes and in rat and human liver microsomes.
    Elaut G; Török G; Vinken M; Laus G; Papeleu P; Tourwe D; Rogiers V
    Drug Metab Dispos; 2002 Dec; 30(12):1320-8. PubMed ID: 12433798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
    Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
    Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat hepatocyte suspensions as a suitable in vitro model for studying the biotransformation of histone deacetylase inhibitors.
    Elaut G; Török G; Papeleu P; Vanhaecke T; Laus G; Tourwé D; Rogiers V
    Altern Lab Anim; 2004 Jun; 32 Suppl 1A():105-12. PubMed ID: 23577441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood.
    Liu L; Detering JC; Milde T; Haefeli WE; Witt O; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():212-21. PubMed ID: 24636840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of ultra high performance liquid chromatography-mass spectrometry method for LBH589 in mouse plasma and tissues.
    Estella-Hermoso de Mendoza A; Imbuluzqueta I; Campanero MA; Gonzalez D; Vilas-Zornoza A; Agirre X; Lana H; Abizanda G; Prosper F; Blanco-Prieto MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3490-6. PubMed ID: 21983199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
    Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pharmacokinetics and metabolism of a novel histone deacetylase inhibitor, KBH-A40, in rats.
    Oh SJ; Lee K; Ryu J; Yu HE; Han G; Park SK; Kang JS; Kim HM; Kim YC
    Xenobiotica; 2011 Feb; 41(2):155-63. PubMed ID: 21070143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures.
    Elaut G; Laus G; Alexandre E; Richert L; Bachellier P; Tourwé D; Rogiers V; Vanhaecke T
    J Pharmacol Exp Ther; 2007 Apr; 321(1):400-8. PubMed ID: 17218485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of PAT-1102, a novel, potent and orally active histone deacetylase inhibitor with antitumor activity in cancer mouse models.
    Hiriyan J; Shivarudraiah P; Gavara G; Annamalai P; Natesan S; Sambasivam G; Sukumaran SK
    Anticancer Res; 2015 Jan; 35(1):229-37. PubMed ID: 25550555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice.
    Otaegui D; Rodríguez-Gascón A; Zubia A; Cossío FP; Pedraz JL
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):153-9. PubMed ID: 19002463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone deacetylase inhibitor trichostatin A influences the development of Drosophila melanogaster.
    Pile LA; Lee FW; Wassarman DA
    Cell Mol Life Sci; 2001 Oct; 58(11):1715-8. PubMed ID: 11706997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X.
    Karagiannis TC; Harikrishnan KN; El-Osta A
    Cancer Biol Ther; 2005 Jul; 4(7):787-93. PubMed ID: 16082178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
    Maxhimer JB; Reddy RM; Zuo J; Cole GW; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):53-63. PubMed ID: 15632825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors.
    Tischler JL; Abuaita B; Cuthpert SC; Fage C; Murphy K; Saxe A; Furr EB; Hedrick J; Meyers J; Snare D; Zand AR
    J Enzyme Inhib Med Chem; 2008 Aug; 23(4):549-55. PubMed ID: 18608778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients.
    Burhenne J; Liu L; Heilig CE; Meid AD; Leisen M; Schmitt T; Kasper B; Haefeli WE; Mikus G; Egerer G
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):433-439. PubMed ID: 28612091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum.
    Parise RA; Holleran JL; Beumer JH; Ramalingam S; Egorin MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Aug; 840(2):108-15. PubMed ID: 16725386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.
    Hakami NY; Dusting GJ; Peshavariya HM
    J Cell Mol Med; 2016 Oct; 20(10):1932-44. PubMed ID: 27297729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells.
    Gan Y; Shen YH; Utama B; Wang J; Coselli J; Wang XL
    Biochem Biophys Res Commun; 2006 Feb; 340(1):29-34. PubMed ID: 16338217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of the yeast nuclear histone deacetylase.
    Sanchez del Pino MM; Lopez-Rodas G; Sendra R; Tordera V
    Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):723-9. PubMed ID: 7980438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.